期刊文献+

微小RNA加工剪切酶Dicer 1 rs1057035多态性与乳腺癌相关性研究 被引量:1

Correlation between Dicer 1 rs1057035 polymorphism and breast cancer
下载PDF
导出
摘要 目的探讨微小RNA加工剪切酶Dicer 1 rs1057035多态性与中国汉族人群乳腺癌的相关性。方法收集176例女性乳腺癌患者和216例健康体检女性的外周静脉血,运用二代测序技术分析Dicer 1 rs1057035多态性在乳腺癌患者和健康体检者中的分布频率。结果Dicer 1 rs1057035基因型分布在女性乳腺癌患者和女性健康体检者中差异无统计学意义(P>0.05)。Dicer 1 rs1057035基因型分布与乳腺癌雌激素受体、孕激素受体、临床分期、肿瘤大小、淋巴结转移无关(P均>0.05)。结论Dicer 1 rs1057035可能不是中国汉族人群乳腺癌发病的易感位点。 Objective To investigate the Dicer 1 rs1057035 polymorphism and risk of breast cancer in the Chinese Han population.Methods Peripheral venous blood was collected from 176 patients with female breast cancer and 216 healthy women.The distribution frequency of Dicer 1 rs1057035 polymorphism in breast cancer and healthy subjects was analyzed by second-generation sequencing technique.Results There was no significant difference in the Dicer 1 rs1057035 genotype distribution between female breast cancer and healthy women(P>0.05).The Dicer 1 rs1057035 genotype distribution had no relationship with estrogen receptor,progesterone receptor,clinical stage,tumor size and lymph node metastasis of breast cancer(P>0.05).Conclusion Dicer 1 rs1057035 may not be a susceptibility locus for the development of breast cancer in the Chinese Han population.
作者 贾文远 芦延峰 冯巍 刘彩媛 秦豪杰 潘新民 JIA Wenyuan;LU Yanfeng;FENG Wei;LIU Caiyuan;QIN Haojie;PAN Xinmin(College of Forensic Medicine,Henan University of Science and Technology,Luoyang 471000,China;Department of Gynecology and Obstetrics,the First Affiliated Hospital,Henan University of Science and Technology,Luoyang 471000,China)
出处 《肿瘤基础与临床》 2021年第4期277-280,共4页 journal of basic and clinical oncology
基金 河南省科技攻关项目(212102310624)。
关键词 乳腺癌 微小RNA Dicer 1 单核苷酸多态性 breast cancer micro RNA Dicer 1 single nucleotide polymorshism
  • 相关文献

参考文献10

二级参考文献81

  • 1Warner E. Clinical practice. Breast cancer screening [J]. N Engl J Med,2011,365(11): 1025-1032.
  • 2Ripperger T,Gadzicki D,Meindl A,et al. Breast cancer sus- ceptibility: current knowledge and implications for genetic counseling [J]. Eur J Hum Genet,2009,17(6): 722-731.
  • 3Meindl A,Hellebrand H,Wiek C,et al. Germline muta- tions in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene[J]. Nat Genet, 2010,42(5):410-414.
  • 4Cao W,Wang X,Li JC. Study of hereditary breast cancer in the Han Chinese population[J]. J Epidemiol,2013,23 (2): 75-84.
  • 5Cao W,Wang X,Gao Y,et al. BRCA1 germ-line muta- tions and tumor characteristics in eastern Chinese women with familial breast cancer [J]. Anat Rec (Hoboken),2013, 296(2): 273-278.
  • 6Fletcher O,Johnson N,Orr N,et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study[J]. J Natl Cancer lnst, 2011,103 (5): 425-435.
  • 7Turnbull C,Ahmed S,Morrison J,et al. Genome-wide as- sociation study identifies five new breast cancer suscepti- bility loci [J]. Nat Genet,2010,42(6): 504-507.
  • 8Pharoah PD,Antoniou AC,Easton DF,et al. Polygenes, risk prediction,and targeted prevention of breast cancer [J]. N Engl J Med,2008,358(26): 2796-2803.
  • 9Filipowicz W, Bhattacharyya SN,Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? [J]. Nat Rev Genet,2008,9(2):102-114.
  • 10Calin GA,Croce CM. MicroRNA signatures in human can- cers [J]. Nat Rev Cancer,2006,6(11):857-866.

共引文献26

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部